These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 15628909

  • 1. Prevalence and clinical correlation of anti-phospholipid-binding protein antibodies in anticardiolipin-negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages.
    Bizzaro N, Tonutti E, Villalta D, Tampoia M, Tozzoli R.
    Arch Pathol Lab Med; 2005 Jan; 129(1):61-8. PubMed ID: 15628909
    [Abstract] [Full Text] [Related]

  • 2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 3. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O, Crippa L, Della Valle P, Sabbadini MG, Viganò D'Angelo S, D'Angelo A.
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [Abstract] [Full Text] [Related]

  • 4. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
    Nojima J, Kuratsune H, Suehisa E, Futsukaichi Y, Yamanishi H, Machii T, Iwatani Y, Kanakura Y.
    Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
    [Abstract] [Full Text] [Related]

  • 5. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C.
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [Abstract] [Full Text] [Related]

  • 6. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P, Tarr T, Tumpek J, Kappelmayer J, Lakos G, Poor G, Szegedi G, Kiss E.
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [Abstract] [Full Text] [Related]

  • 7. Value of IgA anticardiolipin and anti-beta2-glycoprotein I antibody testing in patients with pregnancy morbidity.
    Carmo-Pereira S, Bertolaccini ML, Escudero-Contreras A, Khamashta MA, Hughes GR.
    Ann Rheum Dis; 2003 Jun; 62(6):540-3. PubMed ID: 12759291
    [Abstract] [Full Text] [Related]

  • 8. Antiphospholipid antibody tests: spreading the net.
    Bertolaccini ML, Gomez S, Pareja JF, Theodoridou A, Sanna G, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
    [Abstract] [Full Text] [Related]

  • 9. Acquired activated protein C resistance associated with IgG antibodies against beta2-glycoprotein I and prothrombin as a strong risk factor for venous thromboembolism.
    Nojima J, Kuratsune H, Suehisa E, Iwatani Y, Kanakura Y.
    Clin Chem; 2005 Mar; 51(3):545-52. PubMed ID: 15637132
    [Abstract] [Full Text] [Related]

  • 10. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C, Vlachoyiannopoulos PG, Kordossis T, Moutsopoulos HM.
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [Abstract] [Full Text] [Related]

  • 11. Laboratory evaluation of anti-phospholipid syndrome: a preliminary prospective study of phosphatidylserine/prothrombin antibodies in an at-risk patient cohort.
    Heikal NM, Jaskowski TD, Malmberg E, Lakos G, Branch DW, Tebo AE.
    Clin Exp Immunol; 2015 May; 180(2):218-26. PubMed ID: 25522978
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 13. Detection of anti-annexin IV and V antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Satoh A, Suzuki K, Takayama E, Kojima K, Hidaka T, Kawakami M, Matsumoto I, Ohsuzu F.
    J Rheumatol; 1999 Aug; 26(8):1715-20. PubMed ID: 10451067
    [Abstract] [Full Text] [Related]

  • 14. Anti-beta2-glycoprotein I (GPI) autoantibodies, annexin V binding and the anti-phospholipid syndrome.
    Hanly JG, Smith SA.
    Clin Exp Immunol; 2000 Jun; 120(3):537-43. PubMed ID: 10844535
    [Abstract] [Full Text] [Related]

  • 15. Utility of antiphosphatidylserine/prothrombin and IgA antiphospholipid assays in systemic lupus erythematosus.
    Akhter E, Shums Z, Norman GL, Binder W, Fang H, Petri M.
    J Rheumatol; 2013 Mar; 40(3):282-6. PubMed ID: 23378459
    [Abstract] [Full Text] [Related]

  • 16. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
    Vlachoyiannopoulos PG, Beigbeder G, Dueymes M, Youinou P, Hunt JE, Krilis SA, Moutsopoulos HM.
    Autoimmunity; 1993 Mar; 16(4):245-9. PubMed ID: 8025204
    [Abstract] [Full Text] [Related]

  • 17. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB, Cromar A, Davis KW, Tebo AE.
    Int J Clin Exp Pathol; 2012 Mar; 5(3):210-5. PubMed ID: 22558475
    [Abstract] [Full Text] [Related]

  • 18. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
    Nojima J, Kuratsune H, Suehisa E, Kitani T, Iwatani Y, Kanakura Y.
    Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
    [Abstract] [Full Text] [Related]

  • 19. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V, Verasertniyom O, Vanichapuntu M, Totemchokchyakarn K, Nantiruj K, Pisitkul P, Angchaisuksiri P, Archararit N, Rachakom B, Ayurachai K, Janwityanujit S.
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [Abstract] [Full Text] [Related]

  • 20. Anti-Phosphatidylserine/Prothrombin Antibodies at Two Points: Correlation With Lupus Anticoagulant and Thrombotic Risk.
    Egri N, Bentow C, Rubio L, Norman GL, López-Sañudo S, Mahler M, Pérez-Isidro A, Cervera R, Viñas O, Espinosa G, Ruiz-Ortiz E.
    Front Immunol; 2021 Oct; 12():754469. PubMed ID: 34790198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.